Comparison

BDC2.5 mimotope 1040-31 acetate European Partner

Item no. TMO-TP1541L-100mg
Manufacturer TargetMol
CASRN TP1541L
Amount 100 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles O=C(O)CC[C@@H](C(O)=O)NC([C@H](CCSC)NC([C@H](CCCNC(N)=N)NC([C@H](C(C)C)NC([C@H](CC1=CNC2=C1C=CC=C2)NC([C@H](CC(C)C)NC([C@H]3N(C([C@H](CCCNC(N)=N)NC([C@H](C(C)C)NC([C@H](CC4=CC=C(O)C=C4)N)=O)=O)=O)CCC3)=O)=O)=O)=O)=O)=O.CC(O)=O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias BDC2.5 mimotope 1040-31 acetate(329696-49-3 free base)
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
1408.69
Description
BDC2.5 mimotope 1040-31 acetate is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. It can stimulate BDC2.5 cells with cells showing good response to this mimotope. 1040-31 peptide is specific for BDC2.5 TCR Tg+ (transgenic) T cells. This peptide is also known as p31.
Pathways
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close